← Browse by Condition
Medical Condition

relapsed refractory systemic light chain amyloidosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06292780 Phase 1, Phase 2
Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Enrollment
220 pts
Location
United States, South...
Sponsor
Regeneron Pharmaceuticals
View Trial →